FDA Drug Application (203177) for BACITRACIN by XELLIA PHARMS APS

Back to FDA Applications sponsored by XELLIA PHARMS APS

Application Number203177
Product Number001
FormINJECTABLE;INJECTION
Dosage50,000 UNITS/VIAL
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AP Injectable aqueous solutions and, in certain instances, intravenous non-aqueous solutions
Reference Drug
Drug NameBACITRACIN
Active IngredientBACITRACIN

Active IngredientCount
List of drugs with Active Ingredient BACITRACIN7


Back to FDA Applications sponsored by XELLIA PHARMS APS